Gastrointestinal Cancer
我们是谁
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
给 HLA-A*11:01 患者注射用识别变异 RAS G12D 变异的小鼠 T 细胞受体转导的外周血淋巴细胞
利用 CRISPR 基因工程抑制编码细胞内免疫检查点 CISH 基因的肿瘤浸润淋巴细胞治疗转移性胃肠癌的研究
给 HLA-A*11:01 患者注射用识别变异 RAS G12V 变异的小鼠 T 细胞受体转导的外周血淋巴细胞
